Ascentiz
Category: Robotics / Embodied AI
The world's first modular exoskeleton system designed for outdoor exploration and everyday mobility, featuring a unique swappable architecture for hip and knee support. Ascentiz was founded in 2024. The company is led by Tian Wang. Based in Hangzhou, China. Team size: 10-50. Total funding raised: $60.0M. Latest round: Series B. Key investors include ["SoftBank Vision Fund 2","CICC Capital","BlueRun Ventures","Fosun RZ Capital"].
- Founded
- 2024
- Headquarters
- Hangzhou, China
- Team size
- 10-50
- Total funding
- $60.0M
Value proposition
Offers customizable physical augmentation that adapts to specific activities through a 'plug-and-play' modular system, reducing physical strain and enhancing human endurance in challenging terrains.
Products and solutions
["Ascentiz Modular Exoskeleton Base Frame","Swappable Hip Support Module","Swappable Knee Support Module","BodyOS (Proprietary Robotic Movement Operating System)","Ascentiz Mobile App for performance tracking"]
Unique value
Unlike traditional fixed-frame exoskeletons, Ascentiz uses a modular design that allows users to switch between hip and knee assistance depending on the terrain or specific physical needs.
Target customer
Outdoor enthusiasts (mountaineers, hikers), elderly individuals seeking mobility assistance, and people requiring physical rehabilitation or endurance support.
Industries served
["Consumer Robotics","Outdoor & Sports Gear","Assistive Technology","Healthcare & Rehabilitation"]
Technology advantage
Powered by 'BodyOS,' an intelligent movement operating system that predicts user intent. It leverages medical-grade robotics technology from parent company RoboCT but optimizes it for lightweight, consumer-friendly outdoor use.
How they differentiate
World's first modular architecture allowing users to swap between hip and knee support modules depending on terrain or activity, powered by the proprietary 'BodyOS' movement operating system.
Main competitors
["Hypershell","Dnsys","German Bionic","Skip"]
Key partnerships
["RoboCT (Parent company and R&D backbone)","SoftBank (Strategic investor via parent company)","Professional mountaineering associations (for high-altitude biomechanical validation)","Global consumer electronics distributors for CES-led market entry"]
Notable customers
["Professional Mountaineers (e.g., Feng Sha)","Outdoor Enthusiasts","Elderly individuals seeking mobility assistance"]
Major milestones
["Series B funding led by SoftBank Vision Fund 2 in Jan 2022","Official launch of the Ascentiz consumer brand in 2024","Unveiling of the world's first modular exoskeleton at CES 2026"]
Growth metrics
Holds over 500 patents in wearable robotics; successfully transitioned from medical-grade rehabilitation to consumer outdoor markets with the 2024 brand launch.
Market positioning
Consumer-grade outdoor exploration and mobility assistance brand, bridging the gap between high-end medical robotics and affordable consumer wearables.
Geographic focus
Global (Headquartered in China, with primary market expansion in North America, Europe, and Asia-Pacific).
Patents and IP
Leverages the extensive IP portfolio of parent company RoboCT, which holds over 500 patents in wearable robotics, motion control, and human-machine interaction.
About Tian Wang
Tian Wang is the Founder and CEO of Ascentiz and its parent company, RoboCT. He is a recognized pioneer in wearable robotics, having transitioned medical-grade exoskeleton technology into consumer-ready devices. He was named to the Forbes 30 Under 30 Asia list and has led RoboCT to become a leader in the rehabilitation robotics sector before launching the Ascentiz brand for outdoor and everyday mobility.
Official website: https://ascentizexo.com/